Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Medical and Atrial Fibrillation Management for Atrial FMR

Presenter: Gabriel Sayer

October 29, 2024

Presentation TCT 2024

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Koki Takegawa

October 29, 2024

Presentation TCT 2024

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

Presenter: Ankur Singla

October 29, 2024

Presentation TCT 2024

TCT 108: Atrial Fibrillation Following Patent Foramen Ovale Closure: A Large Single-Center Institutional Experience

Presenter: Arsh Issany

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 544: Utility of C2HEST Score in Predicting Recurrence of Atrial Fibrillation After Catheter Ablation: A Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data

Presenter: Saman Al Barznji

October 28, 2024

Advertisement

December 2024 Dispatch for the CV Team

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Medical and Atrial Fibrillation Management for Atrial FMR

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

TCT 108: Atrial Fibrillation Following Patent Foramen Ovale Closure: A Large Single-Center Institutional Experience

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 544: Utility of C2HEST Score in Predicting Recurrence of Atrial Fibrillation After Catheter Ablation: A Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content